DaVita Inc. (FRA:TRL)

Market Cap	8.54B -38.6%
Revenue (ttm)	11.62B +6.5%
Net Income	636.05M -20.2%
EPS	8.38 -8.3%
Shares Out	n/a
PE Ratio	13.43
Forward PE	10.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	18
Open	125.10
Previous Close	124.65
Day's Range	125.10 - 127.80
52-Week Range	86.70 - 147.70
Beta	n/a
RSI	70.51
Earnings Date	Feb 2, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Employees: 78,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TRL

Financial Performance

In 2025, DaVita's revenue was $13.64 billion, an increase of 6.46% compared to the previous year's $12.82 billion. Earnings were $746.80 million, a decrease of -20.24%.

Financial numbers in USD